Schrodinger Current Ratio 2019-2025 | SDGR
Schrodinger current ratio from 2019 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Schrodinger Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $0.51B | $0.16B | 3.30 |
| 2025-03-31 | $0.57B | $0.17B | 3.45 |
| 2024-12-31 | $0.64B | $0.19B | 3.31 |
| 2024-09-30 | $0.46B | $0.11B | 4.11 |
| 2024-06-30 | $0.45B | $0.10B | 4.50 |
| 2024-03-31 | $0.49B | $0.11B | 4.64 |
| 2023-12-31 | $0.57B | $0.13B | 4.25 |
| 2023-09-30 | $0.55B | $0.11B | 5.22 |
| 2023-06-30 | $0.59B | $0.11B | 5.54 |
| 2023-03-31 | $0.60B | $0.12B | 4.89 |
| 2022-12-31 | $0.53B | $0.11B | 4.91 |
| 2022-09-30 | $0.52B | $0.09B | 5.90 |
| 2022-06-30 | $0.56B | $0.09B | 6.51 |
| 2022-03-31 | $0.59B | $0.09B | 6.85 |
| 2021-12-31 | $0.63B | $0.09B | 6.85 |
| 2021-09-30 | $0.62B | $0.07B | 8.53 |
| 2021-06-30 | $0.65B | $0.07B | 9.23 |
| 2021-03-31 | $0.68B | $0.07B | 9.99 |
| 2020-12-31 | $0.68B | $0.07B | 9.33 |
| 2020-09-30 | $0.62B | $0.04B | 15.81 |
| 2020-06-30 | $0.31B | $0.04B | 7.13 |
| 2020-03-31 | $0.31B | $0.04B | 7.42 |
| 2019-12-31 | $0.12B | $0.05B | 2.63 |
| 2019-09-30 | $0.00B | 0.00 | |
| 2019-06-30 | $0.00B | 0.00 | |
| 2019-03-31 | $0.00B | 0.00 | |
| 2018-12-31 | $0.11B | $0.03B | 3.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.410B | $0.208B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.104B | 58.65 |
| Doximity (DOCS) | United States | $12.505B | 55.48 |
| Hims & Hers Health (HIMS) | United States | $11.626B | 96.18 |
| Tempus AI (TEM) | United States | $10.538B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.092B | 0.00 |
| Hinge Health (HNGE) | United States | $4.422B | 0.00 |
| Privia Health (PRVA) | United States | $2.526B | 187.09 |
| Inspire Medical Systems (INSP) | United States | $2.341B | 34.41 |
| Enovis (ENOV) | United States | $1.626B | 8.59 |
| Phreesia (PHR) | United States | $1.607B | 0.00 |
| 10x Genomics (TXG) | United States | $1.513B | 0.00 |
| Omnicell (OMCL) | United States | $1.416B | 27.28 |
| Clover Health Investments (CLOV) | United States | $1.109B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Claritev (CTEV) | United States | $0.934B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.623B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.496B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| Zepp Health (ZEPP) | Netherlands | $0.360B | 0.00 |
| Carlsmed (CARL) | $0.337B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.284B | 49.76 |
| Nyxoah SA (NYXH) | Belgium | $0.253B | 0.00 |
| Outset Medical (OM) | United States | $0.227B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.215B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.197B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.113B | 5.14 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |